Showing results (841-850 of 922) with videos related to

Sort By:
Pageof 93
Research Square|February 26, 2024
Repurposing mebendazole against triple-negative breast cancer leptomeningeal diseaseAdrian Rodrigues, Sophia B Chernikova, Yuelong Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2023
A Metabolically Optimized, Noncytotoxic Low-Dose Weekly Decitabine/Venetoclax in MDS and AMLDavid Levitz, Yogen Saunthararajah, Kateryna Fedorov, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|March 20, 2024
Pediatric non-galenic pial arteriovenous fistula's characteristics and outcomes: a systematic reviewGarrett W Thrash, Andrew T Hale, Michael J Feldman, et al.
Stroke (Hoboken, N.J.)|October 3, 2022
Saline versus Balanced Crystalloids for Adults with Aneurysmal Subarachnoid Hemorrhage: A Subgroup Analysis of the SMART TrialAkshitkumar M Mistry, Jordan A Magarik, Michael J Feldman, et al.
Nature Immunology|May 26, 2015
Diversity, cellular origin and autoreactivity of antibody-secreting cell population expansions in acute systemic lupus erythematosusChristopher M Tipton, Christopher F Fucile, Jaime Darce, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 14, 2019
SWOG S1400D (NCT02965378), a Phase II Study of the Fibroblast Growth Factor Receptor Inhibitor AZD4547 in Previously Treated Patients With Fibroblast Growth Factor Pathway-Activated Stage IV Squamous Cell Lung Cancer (Lung-MAP Substudy)Charu Aggarwal, Mary W Redman, Primo N Lara, et al.
Journal of Neuro-Oncology|April 2, 2024
Repurposing mebendazole against triple-negative breast cancer CNS metastasisAdrian J Rodrigues, Sophia B Chernikova, Yuelong Wang, et al.
Nature Genetics|November 14, 1997
Opitz G/BBB syndrome, a defect of midline development, is due to mutations in a new RING finger gene on Xp22N A Quaderi, S Schweiger, K Gaudenz, et al.
Pageof 93